2 patents
Utility
Mesenchymal stem cells for the treatment of CNS diseases
30 Nov 21
An isolated human cell is disclosed comprising at least one mesenchymal stem cell phenotype and secreting brain-derived neurotrophic factor (BDNF), wherein a basal secretion of the BDNF is at least five times greater than a basal secretion of the BDNF in a mesenchymal stem cell.
Avinoam Kadouri, Avihay Bar-Ilan, Eldad Melamed, Daniel Offen, Ofer Sadan, Merav Bahat-Stromza
Filed: 27 Jul 18
Utility
Populations of mesenchymal stem cells that secrete neurotrophic factors
17 Feb 20
Yael Gothelf, Yosef Levy
Filed: 10 Feb 15
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first